A Sai Datri, A Lakshmana Rao, Ch Purna Durganjali
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
A simple, accurate, precise RP-HPLC method was developed for the simultaneous estimation of the Metformin and Empagliflozin in the tablet dosage form. Materials and Methods: Chromatogram was run through Std Agilent 18 (150 x 4.6mm, 5μm). Mobile phase taken as 0.1% OPA Buffer: Acetonitrile in 60:40% v/v ratio, and pumped through the column at a flow rate of 1mL/min. The buffer used in this method was 0.1% OPA buffer. The temperature was maintained at 25°C. Results and Discussion: Optimized wave length selected was 245 nm. The retention times of Metformin and Empagliflozin were found to be 2.193 min and 2.668 min respectively. %RSD of the Metformin and Empagliflozin was found to be 1.4 and 0.8 respectively. % Recovery was obtained as 99.66% and 100.24% for Metformin and Empagliflozin respectively. LOD, LOQ values obtained from regression equations of Metformin and Empagliflozin were 0.02, 1.48, and 0.05, 4.93 respectively. Regression equation of Metformin is y =20952x + 9914.5 and y = 41842x + 571.79 of Empagliflozin. Retention times were decreased and that run time was decreased, The Reverse Phase HPLC isocratic method for Metformin and Empagliflozin is developed and validated as per ICH guidelines. Conclusion: The test method is found to be sensitive, accurate, precise, linear, convenient, and economical that can be adopted in regular quality control tests in Industries.
A Sai Datri, A Lakshmana Rao, Ch Purna Durganjali/Novel Approach of Stability Indicating Method Development for Determination of Metformin and Empagliflozin by High Performance Liquid Chromatography/ J Pharmaceut Med Chem. 2022;8(2):53-61.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| March 09, 2022 | June 10, 2022 | December 25, 2022 |
Monday 07 September 2026, 22:17:11 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | March 09, 2022 |
| Accepted | June 10, 2022 |
| Published | December 25, 2022 |
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.